I am trying to analyze data that sequenced targeted regions of the genome (about 500 Mb in total). In the GATK pipeline it suggests marking duplicates/removing duplicates. Is this important to do with targeted sequencing? Wouldn't you expect duplicates because of the experimental design? Thanks!
-
-
Yes. If you have PCR or optical duplicates you will want to remove them before variant calling or you may introduce spurious variant calls.
It does depend what method you have used to do the capture, some methods are not amenable to deduplication - amplicon based approaches etc. A straightforward in-solution capture approach will be fine because you've randomly sheared your DNA before capture, and therefore you shouldn't expect lots of read pairs with the same coordinates when mapped.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment